DPhil research opportunities 2024
The admissions cycle for entry in October 2024 is now open. Please continue to check this webpage for new opportunities as they are added.
| Title | |
|---|---|
| Andersson Group - Occult hepatitis B virus infection (OBI) in people who donate blood: virology, immunology and liver health (OPAL) Andersson Group - Occult hepatitis B virus infection (OBI) in people who donate blood: virology, immunology and liver health (OPAL) | Monique Andersson |
| Simmons Group - Characterising Human Intestinal Development and Dysregulation in Childhood Diseases Simmons Group - Characterising Human Intestinal Development and Dysregulation in Childhood Diseases | Alison Simmons |
| Antanaviciute Group - Characterising spatial tissue niches in human immune system development and disease using computational biology, machine learning and multi-omics approaches Antanaviciute Group - Characterising spatial tissue niches in human immune system development and disease using computational biology, machine learning and multi-omics approaches | Agne Antanaviciute |
| Koohy Group - Applications of multi-omics and AI to decode T cell recognition code in time and space Koohy Group - Applications of multi-omics and AI to decode T cell recognition code in time and space | Hashem Koohy |
| MRC Enterprise Studentship - Imaging-based analysis of signalling pathways triggered by immune checkpoint receptors MRC Enterprise Studentship - Imaging-based analysis of signalling pathways triggered by immune checkpoint receptors | Simon Davis |
| Tyler Group - Development and Application of Hyperpolarized Magnetic Resonance Imaging in the Study of the Diseased Heart Tyler Group - Development and Application of Hyperpolarized Magnetic Resonance Imaging in the Study of the Diseased Heart | Damian Tyler |
| Chakraverty Group - Design of advanced haematopoietic stem cell and T cell therapies Chakraverty Group - Design of advanced haematopoietic stem cell and T cell therapies | Ronjon Chakraverty |
| Antoniades Group - Cross-talk between adipose tissue and the cardiovascular system in humans: Using Artificial Intelligence to design precision Imaging diagnostics and discover novel therapeutic targets Antoniades Group - Cross-talk between adipose tissue and the cardiovascular system in humans: Using Artificial Intelligence to design precision Imaging diagnostics and discover novel therapeutic targets | Charalambos Antoniades |
| Douglas Group - Functional coronary artery disease genetics - defining the function of new causal atherosclerosis genes Douglas Group - Functional coronary artery disease genetics - defining the function of new causal atherosclerosis genes | Gillian Douglas |
| Karpe Group - Human fat distribution and metabolic disease Karpe Group - Human fat distribution and metabolic disease | Fredrik Karpe |
| Leeson Group - Imaging in Preventive Cardiology Research Leeson Group - Imaging in Preventive Cardiology Research | Paul Leeson |
| Reilly Group - Adverse myocardial remodelling in cardiac fibrosis and atrial fibrillation Reilly Group - Adverse myocardial remodelling in cardiac fibrosis and atrial fibrillation | Svetlana Reilly |
| Tzima Group - Why does turbulent blood flow cause cardiovascular disease? Tzima Group - Why does turbulent blood flow cause cardiovascular disease? | Ellie Tzima |
| Watkins Group – Various projects relating to inherited heart muscle disease Watkins Group – Various projects relating to inherited heart muscle disease | Hugh Watkins |
| Drakesmith Group - Iron Biology Drakesmith Group - Iron Biology | Hal Drakesmith |
| Goriely Group - De Novo Mutations and Human Disease Goriely Group - De Novo Mutations and Human Disease | Anne Goriely |
| Higgs Group - Understanding the principles of gene expression in health and disease. Higgs Group - Understanding the principles of gene expression in health and disease. | Douglas Higgs |
| Mead Group - Inflammation in p53 mutant myeloproliferative neoplasms Mead Group - Inflammation in p53 mutant myeloproliferative neoplasms | Adam Mead |
| Psaila Group - Developing improved models of normal and malignant blood cell development Psaila Group - Developing improved models of normal and malignant blood cell development | Bethan Psaila |
| Twigg Group - Building the skull – normal and abnormal development Twigg Group - Building the skull – normal and abnormal development | Stephen Twigg |
| Toepfer Group - Elucidating the role of disease modifying gene variants in inherited cardiomyopathies using induced pluripotent stem cell derived cardiomyocytes and CRISPR/Cas-9 Toepfer Group - Elucidating the role of disease modifying gene variants in inherited cardiomyopathies using induced pluripotent stem cell derived cardiomyocytes and CRISPR/Cas-9 | Christopher Toepfer |
| Hyde Group - Airway Gene Therapy - Engineering Lentiviral Vectors for Lung Cell-Specific Targeting Hyde Group - Airway Gene Therapy - Engineering Lentiviral Vectors for Lung Cell-Specific Targeting | Stephen Hyde |
| Chapman Group - Homologous recombination in genome maintenance and cancer prevention Chapman Group - Homologous recombination in genome maintenance and cancer prevention | Ross Chapman |
| Pavlides Group - Non-invasive tests for the prediction of clinical outcomes in people with metabolic dysfunction associated steatotic liver disease Pavlides Group - Non-invasive tests for the prediction of clinical outcomes in people with metabolic dysfunction associated steatotic liver disease | Michael Pavlides |
| Grist group - Development and combination of advanced neuroimaging to understand functional changes in Multiple Sclerosis Grist group - Development and combination of advanced neuroimaging to understand functional changes in Multiple Sclerosis | James Grist |
| Davies Group – Genomics and Genome Editing Davies Group – Genomics and Genome Editing | James Davies |
| Davis Group - Therapeutic opportunities emerging from studies of immune checkpoints Davis Group - Therapeutic opportunities emerging from studies of immune checkpoints | Simon Davis |
| David Hodson Group - Understanding how glucagon-like peptide-1 (GLP1) and gastric inhibitory polypeptide (GIP) receptors contribute to metabolism in complex tissues David Hodson Group - Understanding how glucagon-like peptide-1 (GLP1) and gastric inhibitory polypeptide (GIP) receptors contribute to metabolism in complex tissues | David Hodson |
| Reader Group - How do protein making factories prevent cardiovascular disease? Reader Group - How do protein making factories prevent cardiovascular disease? | John Reader |
| Ormondroyd Group - Development of genetic therapies for cardiomyopathy: creating an evidence base for ethical and clinical implementation. Ormondroyd Group - Development of genetic therapies for cardiomyopathy: creating an evidence base for ethical and clinical implementation. | Elizabeth Ormondroyd |
| Royston Group - Advanced early detection of lytic bone disease using multi-modal computational analysis of bone marrow biopsies and skeletal imaging Royston Group - Advanced early detection of lytic bone disease using multi-modal computational analysis of bone marrow biopsies and skeletal imaging | |
| Patel, de Bruijn and Roy Groups - Impact of endogenous DNA damage and repair in early haematopoiesis Patel, de Bruijn and Roy Groups - Impact of endogenous DNA damage and repair in early haematopoiesis | KJ Patel |
| Valkovič Group - Non-invasive cardiac metabolism assessment using ultra-high field (7T) MR Spectroscopy Valkovič Group - Non-invasive cardiac metabolism assessment using ultra-high field (7T) MR Spectroscopy | Ladislav Valkovic |
| Akbar Group - Generating extracellular vesicles for therapeutic Immunomodulation and building tools to determine their diagnostic potential. Akbar Group - Generating extracellular vesicles for therapeutic Immunomodulation and building tools to determine their diagnostic potential. | Naveed Akbar |